Foster City, CA, United States of America

Maria Geraldine Venthoye

This inventor holds 1 USPTO granted patent. Top assignee: Novartis Ag. Active years: 2016.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Maria Geraldine Venthoye. Retrieved from https://idiyas.com/inventor/maria-geraldine-venthoye

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2016

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Maria Geraldine Venthoye: Innovator in Pulmonary Delivery Systems

Introduction

Maria Geraldine Venthoye is a notable inventor based in Foster City, California. She has made significant contributions to the field of medicine, particularly in the administration of aminoglycosides. Her innovative approach focuses on improving the treatment of respiratory infections through targeted delivery methods.

Latest Patents

Maria holds a patent for her invention titled "Pulmonary delivery of aminoglycoside." This invention is directed to the administration of aminoglycosides, specifically through pulmonary methods. The patent outlines compositions and methods that facilitate localized treatment for respiratory infections, showcasing her commitment to advancing medical technology.

Career Highlights

Maria is currently employed at Novartis AG, a leading global healthcare company. Her work at Novartis allows her to collaborate with other experts in the field and contribute to groundbreaking research and development in pharmaceuticals.

Collaborations

Throughout her career, Maria has worked alongside esteemed colleagues such as Thomas E. Tarara and Jeffry G. Weers. These collaborations have further enriched her research and innovation efforts.

Conclusion

Maria Geraldine Venthoye exemplifies the spirit of innovation in the medical field with her patent on pulmonary delivery systems. Her work not only enhances treatment options for patients but also reflects the importance of targeted therapies in modern medicine.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…